Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis

Objective. To identify any concomitant complications other than bleeding (COTB) before and after endoscopic treatment of esophagogastric variceal bleeding (EGVB) in liver cirrhosis patients and explore the underlying risk factors. Materials and Methods. Cirrhotic patients complicated with EGVB, who...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaowei Duan, Xing He, Hezhong Yan, Haiqing Li, Jiaoxue Wang, Shicun Guo, Zhengwei Zha, Qianqian Zhang, Yuchuan Bai, Jiayi Zhang, Jun Tang, Derun Kong
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2023/7556408
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849765753906003968
author Xiaowei Duan
Xing He
Hezhong Yan
Haiqing Li
Jiaoxue Wang
Shicun Guo
Zhengwei Zha
Qianqian Zhang
Yuchuan Bai
Jiayi Zhang
Jun Tang
Derun Kong
author_facet Xiaowei Duan
Xing He
Hezhong Yan
Haiqing Li
Jiaoxue Wang
Shicun Guo
Zhengwei Zha
Qianqian Zhang
Yuchuan Bai
Jiayi Zhang
Jun Tang
Derun Kong
author_sort Xiaowei Duan
collection DOAJ
description Objective. To identify any concomitant complications other than bleeding (COTB) before and after endoscopic treatment of esophagogastric variceal bleeding (EGVB) in liver cirrhosis patients and explore the underlying risk factors. Materials and Methods. Cirrhotic patients complicated with EGVB, who underwent interventional endoscopic treatments in our hospital from November 2017 to August 2020, were enrolled in this study. Clinical data were retrospectively analyzed for COTB at admission and within 2 years of the first endoscopic treatment. Patients were screened for potential risk factors of COTB before and after the treatment. Univariate analysis was performed to identify clinical factors of secondary complications, and statistically significant factors were included in the multivariate Cox and logistic regression analyses. Results. Of the 547 patients with cirrhosis, 361 individuals had COTB in the first endoscopic treatment. In this cohort, the top 3 prevalent incidences were portal vein thrombosis (PVT) or spongiosis, cholelithiasis, and pathogenic infections. The COTB did not occur at admission in 171 liver cirrhosis patients but happened at the follow-up. Higher Child-Pugh scores indicated potential risks of multiple concurrent complications, including bleeding. Risk factors for concomitant PVT or cavernous changes after endoscopic treatment of EGVB, pathogenic infections, and cholelithiasis could prolong the cirrhosis symptoms, while noncholestatic cirrhosis patients might have a lower risk than posthepatitis B cirrhosis patients, in the context of a higher degree of EGV and serum level of D-D and a lower blood calcium level. Conclusions. Clinical treatment and interventions can be tailored to avoid other complications during and after EGVB treatment, which can affect the outcome and prognosis of bleeding symptoms.
format Article
id doaj-art-cadbc964e9434e05a6891d41ab5eed08
institution DOAJ
issn 2291-2797
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-cadbc964e9434e05a6891d41ab5eed082025-08-20T03:04:46ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27972023-01-01202310.1155/2023/7556408Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver CirrhosisXiaowei Duan0Xing He1Hezhong Yan2Haiqing Li3Jiaoxue Wang4Shicun Guo5Zhengwei Zha6Qianqian Zhang7Yuchuan Bai8Jiayi Zhang9Jun Tang10Derun Kong11Department of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyObjective. To identify any concomitant complications other than bleeding (COTB) before and after endoscopic treatment of esophagogastric variceal bleeding (EGVB) in liver cirrhosis patients and explore the underlying risk factors. Materials and Methods. Cirrhotic patients complicated with EGVB, who underwent interventional endoscopic treatments in our hospital from November 2017 to August 2020, were enrolled in this study. Clinical data were retrospectively analyzed for COTB at admission and within 2 years of the first endoscopic treatment. Patients were screened for potential risk factors of COTB before and after the treatment. Univariate analysis was performed to identify clinical factors of secondary complications, and statistically significant factors were included in the multivariate Cox and logistic regression analyses. Results. Of the 547 patients with cirrhosis, 361 individuals had COTB in the first endoscopic treatment. In this cohort, the top 3 prevalent incidences were portal vein thrombosis (PVT) or spongiosis, cholelithiasis, and pathogenic infections. The COTB did not occur at admission in 171 liver cirrhosis patients but happened at the follow-up. Higher Child-Pugh scores indicated potential risks of multiple concurrent complications, including bleeding. Risk factors for concomitant PVT or cavernous changes after endoscopic treatment of EGVB, pathogenic infections, and cholelithiasis could prolong the cirrhosis symptoms, while noncholestatic cirrhosis patients might have a lower risk than posthepatitis B cirrhosis patients, in the context of a higher degree of EGV and serum level of D-D and a lower blood calcium level. Conclusions. Clinical treatment and interventions can be tailored to avoid other complications during and after EGVB treatment, which can affect the outcome and prognosis of bleeding symptoms.http://dx.doi.org/10.1155/2023/7556408
spellingShingle Xiaowei Duan
Xing He
Hezhong Yan
Haiqing Li
Jiaoxue Wang
Shicun Guo
Zhengwei Zha
Qianqian Zhang
Yuchuan Bai
Jiayi Zhang
Jun Tang
Derun Kong
Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis
Canadian Journal of Gastroenterology and Hepatology
title Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis
title_full Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis
title_fullStr Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis
title_full_unstemmed Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis
title_short Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis
title_sort analysis of complications and risk factors other than bleeding before and after endoscopic treatment of esophagogastric variceal bleeding in patients with liver cirrhosis
url http://dx.doi.org/10.1155/2023/7556408
work_keys_str_mv AT xiaoweiduan analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT xinghe analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT hezhongyan analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT haiqingli analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT jiaoxuewang analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT shicunguo analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT zhengweizha analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT qianqianzhang analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT yuchuanbai analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT jiayizhang analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT juntang analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis
AT derunkong analysisofcomplicationsandriskfactorsotherthanbleedingbeforeandafterendoscopictreatmentofesophagogastricvaricealbleedinginpatientswithlivercirrhosis